YouTube Facebook LinkedIn Google+ Twitter Xingrss  

Briefs


Oct. 8, 2008

Petaflop Power
NVIDIA
GPUs are contributing over 1 petaflop of processing power to Stanford University’s Folding@home distributed computing network, nearly half of the processing power of the entire project. NVIDIA’s contribution is delivered by 11,370 of the total active processors used in the project. Folding@home is Stanford’s distributed computing program used to simulate protein folding. Protein-folding simulations can be done 140 times faster on an NVIDIA GPU than on traditional CPUs.

Web-Enabled EDC
Phase Forward
acquired Radnor, PA-based Clarix for $40 million cash. Clarix provides Web-integrated interactive response technology (IRT) used for subject randomization, operational management, and reporting in clinical trials. Phase Forward plans to integrate Clarix’ Web-integrated features into its InForm electronic data capture tool. Clarix’ platform allows customers to set up clinical trials in half the time of tradition IRT providers.

Antibody Atlas
Sigma-Aldrich
has announced the addition of  2,000 new, highly validated antibodies to the Human Protein Atlas, a non-commercial endeavor of the Human Proteome Resource. Sigma-Aldrich exclusively provides these antibodies to researchers in its Prestige Antibodies library. The Atlas now includes 3,800 antibodies directed against 3,600 genes.

German Acquisition
Bayer has acquired Germany’s Direvo Biotech for $299 million. Direvo specializes in protein engineering, and will give Bayer a boost in manufacturing biological drugs, such as antibodies, that would presumably add to Bayer’s drug unit, which last month won the first approval of Xarelto.

___________________________________________________

This article appeared in Bio-IT World Magazine.

Subscriptions are free for qualifying individuals.  Apply Today.

 

View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.